Synthetic Biologics Inc. | Mutual Funds
Mutual Funds that own Synthetic Biologics Inc.
Vanguard Total Stock Market Index Fund
86,702
2.27%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
38,746
1.02%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
15,210
0.4%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
5,656
0.15%
0
0%
07/31/2018
Mont Blanc China Opportunity Fund
2,857
0.08%
0
0.33%
07/31/2018
Fidelity Spartan Total Market Index Fund
2,422
0.06%
0
0%
07/31/2018
Vanguard Balanced Index Fund
1,228
0.03%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
1,090
0.03%
0
0%
09/06/2018
867
0.02%
0
0.01%
09/05/2018
Vanguard Total Stock Market Index Trust
729
0.02%
0
0%
07/31/2018
| Address |
9605 Medical Center Drive
Rockville Maryland 20850
United States
|
|
Employees
|
- |
| Website |
http://www.syntheticbiologics.com |
| Updated |
07/08/2019 |
| Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004. The SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation. |
